Log In
BCIQ
Print this Print this
 

TT-302

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionSmall molecule that inhibits the overproduction of inflammatory cytokine
Molecular Target Interleukin-1 (IL-1) beta
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$60.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/31/2016

$60.0M

0

0

Get a free BioCentury trial today